Webinar: Rare and Orphan Diseases Patient Perceptions

Sponsored by: Covance

Focused on:

  • Rare Disease
  • Orphan Drug
  • Clinical Trials

Date: 4 May

Days to go: 11

Time: 4PM London/11AM New York

Implications for Recruitment, Retention and Compliance in Clinical Trials

Do you face the challenge of recruiting and retaining rare disease patients for orphan drug clinical trials? Now, discover how you can boost participation, enhance outcomes and speed drug development in this competitive market. Join Dr. Rolando Gutierrez-Esteinou, MD, Vice President, Therapeutic Area Head, Neuroscience Medical and Scientific Services at Covance, for this timely Webinar.

Gain game-changing insights as we:

⚫ Identify key aspects of rare disease patients’ mindset and views on logistical elements of clinical trial participation.
⚫ Recognize potential implications of patients’ views on clinical trial recruitment, retention and compliance.
⚫ Preview more advanced patient survey designs with the aim of further enhancing rare or orphan disease clinical trials.

You’ll take away tips and tools to make your next orphan drug clinical trial more successful ─ saving time and money with better results.

Learn how to build better trials for rare diseases. Register today!

Presented by

Rolando Gutierrez-Esteinou, MD,

Vice President, Therapeutic Area Head Neuroscience Medical and Scientific Services, Covance Inc

Dr. Gutierrez currently serves as the head of Covance's Neuroscience therapeutic area.

In this role, he has oversight for all studies in Neuroscience conducted by Covance across the globe. Dr. Gutierrez previously held positions in the Neuroscience franchises at J&J, Novartis and BMS where he had worldwide responsibility for the development of compounds in both psychiatric and neurologic indications. He has more than 20 years of pharmaceutical development experience in Clinical Development, Project Management and Medical Affairs. He has led or supervised the development of compounds in a range of neuroscience indications, including rare and orphan diseases.

Key Learning Objectives

  • Identify key aspects of rare disease patients’ mindset and views on logistical elements of clinical trial participation
  • Recognize potential implications of patients’ views on clinical trial recruitment, retention and compliance
  • Preview more advanced patient survey designs with the aim of further enhancing rare or orphan disease clinical trials

Audience

  • Head / Manager of Operations
  • Rare Disease R&D Specialists
  • Orphan Drug R&D Specialists
  • Clinical Trials Specialists